Marjorie E. Koenen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Marjorie E. Koenen has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Ateequr Rehman
Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany
2 shared publications - Femke-Anouska Heinsen
Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
2 shared publications Koen Venema
2 shared publications- Koen Venema
TNO, P.O. Box 360, 3700 AJ Zeist, The Netherlands
2 shared publications - Koen Venema
Centre for Healthy Eating & Food Innovation, Campus Venlo, Maastricht University, Villafloraweg 1, 5928 SZ Venlo, The Netherlands
2 shared publications - Marisol Aguirre
Top Institute of Food & Nutrition, PO Box 557, 6700 AA Wageningen, The Netherlands; Maastricht University, School for Nutrition and Translational Research in Metabolism (NUTRIM), Faculty of Health, Medicine and Life Sciences, Department of Human Biology, PO Box 616, 6200 MD Maastricht, The Netherlands; The Netherlands Organization for Applied Scientific Research, TNO, PO Box 360, 3700 AJ Zeist, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 19 April 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (4) , e0214859
Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers
In developing an oral bait BCG vaccine against tuberculosis in badgers we wanted to understand the conditions of the gastrointestinal tract and their impact on vaccine viability. Conditions mimicking stomach and small-intestine caused substantial reduction in BCG viability. We performed in vivo experiments using a telemetric pH monitoring system and used the data to parameterise a dynamic in vitro system (TIM-1) of the stomach and small intestine. Some BCG died in the stomach compartment and through the duodenum and jejunum compartments. BCG survival in the stomach was greatest when bait was absent but by the time BCG reached the jejunum, BCG viability was not significantly affected by the presence of bait. Our data suggest that from a starting quantity of 2.85 ± 0.45 x 108 colony-forming units of BCG around 2 log10 may be killed before delivery to the intestinal lymphoid tissue. There are economic arguments for reducing the dose of BCG to vaccinate badgers orally. Our findings imply this could be achieved if we can protect BCG from the harsh environment of the stomach and duodenum. TIM-1 is a valuable, non-animal model with which to evaluate and optimise formulations to maximise BCG survival in the gastrointestinal tract.
- 19 April 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (4) , e0214859
Open AccessSurvival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers
In developing an oral bait BCG vaccine against tuberculosis in badgers we wanted to understand the conditions of the gastrointestinal tract and their impact on vaccine viability. Conditions mimicking stomach and small-intestine caused substantial reduction in BCG viability. We performed in vivo experiments using a telemetric pH monitoring system and used the data to parameterise a dynamic in vitro system (TIM-1) of the stomach and small intestine. Some BCG died in the stomach compartment and through the duodenum and jejunum compartments. BCG survival in the stomach was greatest when bait was absent but by the time BCG reached the jejunum, BCG viability was not significantly affected by the presence of bait. Our data suggest that from a starting quantity of 2.85 ± 0.45 x 108 colony-forming units of BCG around 2 log10 may be killed before delivery to the intestinal lymphoid tissue. There are economic arguments for reducing the dose of BCG to vaccinate badgers orally. Our findings imply this could be achieved if we can protect BCG from the harsh environment of the stomach and duodenum. TIM-1 is a valuable, non-animal model with which to evaluate and optimise formulations to maximise BCG survival in the gastrointestinal tract.
- 1 October 2015
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 117, 78-84
Evaluation of an optimal preparation of human standardized fecal inocula for in vitro fermentation studies
- 1 October 2015
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 117, 78-84
Evaluation of an optimal preparation of human standardized fecal inocula for in vitro fermentation studies
- 1 December 2014
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 107, 1-7
To pool or not to pool? Impact of the use of individual and pooled fecal samples for in vitro fermentation studies
- 1 December 2014
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 107, 1-7
To pool or not to pool? Impact of the use of individual and pooled fecal samples for in vitro fermentation studies
- 1 November 2014
- Published by Elsevier in Journal of Functional Foods
- Vol. 11, 210-220
Prebiotic effects of cassava bagasse in TNO's in vitro model of the colon in lean versus obese microbiota
- 1 November 2014
- Published by Elsevier in Journal of Functional Foods
- Vol. 11, 210-220
Prebiotic effects of cassava bagasse in TNO's in vitro model of the colon in lean versus obese microbiota
- Open Access
- 5 September 2013
- Published by Wiley in Food Science & Nutrition
- Vol. 1 (6) , 409-415
The bioaccessibility of eicosapentaenoic acid was higher from phospholipid food products than from mono‐ and triacylglycerol food products in a dynamic gastrointestinal model
The bioaccessibility of eicosapentaenoic acid (EPA) in the forms of monoacylglycerol (EPA‐MAG), triacylglycerol (EPA‐TAG), and phospholipid (EPA‐PL) during gastrointestinal passage was compared in this study using a dynamic gastrointestinal model (TIM system). The TIM system simulated the average upper gastrointestinal tract conditions of healthy human adults after intake of a meal (fed state conditions). In this study, the three EPA‐rich oils were separately homogenized with full fat milk to obtain oil‐in‐water emulsions. Plain yogurt was added into the mixture at an emulsion/yogurt ratio of 4:1 (w/w) as the food matrix of the test products. The results show that the test meals containing EPA‐PL left the stomach compartment most efficiently in comparison with the gastric emptying of EPA‐MAG and EPA‐TAG. The PLs also showed a significantly (P < 0.05) higher bioaccessibility of EPA (75–80%) in comparison with MAG (30%) and TAG (38%). The better gastric emptying of EPA‐PL was likely related to the more stable emulsion of EPA‐PL in the test meal. EPA‐PL was delivered within the meal matrix into the duodenum instead of floating on the top of the test meal matrix. EPA‐MAG had the highest amount of EPA that did not leave the stomach (68% of the test meal). The results from this work indicate that EPA‐PL is a more effective form of EPA for a higher lipid bioaccessibility than MAG and TAG under the test conditions.
- 5 September 2013
- Published by Wiley in Food Science & Nutrition
- Vol. 1 (6) , 409-415
Open AccessThe bioaccessibility of eicosapentaenoic acid was higher from phospholipid food products than from mono‐ and triacylglycerol food products in a dynamic gastrointestinal model
The bioaccessibility of eicosapentaenoic acid (EPA) in the forms of monoacylglycerol (EPA‐MAG), triacylglycerol (EPA‐TAG), and phospholipid (EPA‐PL) during gastrointestinal passage was compared in this study using a dynamic gastrointestinal model (TIM system). The TIM system simulated the average upper gastrointestinal tract conditions of healthy human adults after intake of a meal (fed state conditions). In this study, the three EPA‐rich oils were separately homogenized with full fat milk to obtain oil‐in‐water emulsions. Plain yogurt was added into the mixture at an emulsion/yogurt ratio of 4:1 (w/w) as the food matrix of the test products. The results show that the test meals containing EPA‐PL left the stomach compartment most efficiently in comparison with the gastric emptying of EPA‐MAG and EPA‐TAG. The PLs also showed a significantly (P < 0.05) higher bioaccessibility of EPA (75–80%) in comparison with MAG (30%) and TAG (38%). The better gastric emptying of EPA‐PL was likely related to the more stable emulsion of EPA‐PL in the test meal. EPA‐PL was delivered within the meal matrix into the duodenum instead of floating on the top of the test meal matrix. EPA‐MAG had the highest amount of EPA that did not leave the stomach (68% of the test meal). The results from this work indicate that EPA‐PL is a more effective form of EPA for a higher lipid bioaccessibility than MAG and TAG under the test conditions.
- 25 July 2013
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 61 (31) , 7636-7644
Digestibility of Transglutaminase Cross-Linked Caseinate versus Native Caseinate in an In Vitro Multicompartmental Model Simulating Young Child and Adult Gastrointestinal Conditions
Aim of this study was to investigate the digestion of transglutaminase cross-linked caseinate (XLC) versus native caseinate (NC) in solution and in cheese spread under digestive conditions for adults and children mimicked in a gastrointestinal model. Samples were collected for gel electrophoresis and nitrogen analysis. The results showed no relevant differences between XLC and NC for total and α-amino nitrogen in digested fraction under adult and child conditions. However, the rate of digestion was depending on the food matrix. Gel electrophoresis showed the gastric breakdown of XLC without formation of pepsin resistant peptides larger than 4 kDa. NC was slowly digested in the stomach with formation of pepsin resistant fragments and was still detectable in the stomach after 90 min. In the small intestine the proteins were rapidly digested. XLC was digested to small peptides, while NC was resistant against pepsin digestion under gastric conditions of adults and children.
- 25 July 2013
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 61 (31) , 7636-7644
Digestibility of Transglutaminase Cross-Linked Caseinate versus Native Caseinate in an In Vitro Multicompartmental Model Simulating Young Child and Adult Gastrointestinal Conditions
Aim of this study was to investigate the digestion of transglutaminase cross-linked caseinate (XLC) versus native caseinate (NC) in solution and in cheese spread under digestive conditions for adults and children mimicked in a gastrointestinal model. Samples were collected for gel electrophoresis and nitrogen analysis. The results showed no relevant differences between XLC and NC for total and α-amino nitrogen in digested fraction under adult and child conditions. However, the rate of digestion was depending on the food matrix. Gel electrophoresis showed the gastric breakdown of XLC without formation of pepsin resistant peptides larger than 4 kDa. NC was slowly digested in the stomach with formation of pepsin resistant fragments and was still detectable in the stomach after 90 min. In the small intestine the proteins were rapidly digested. XLC was digested to small peptides, while NC was resistant against pepsin digestion under gastric conditions of adults and children.
- Open Access
- 18 June 2012
- Published by Co-Action Publishing in Microbial Ecology in Health and Disease
- Vol. 23
Isolation of bifidobacteria for blood group secretor status targeted personalised nutrition
Currently, there is a constant need to find microbial products for maintaining or even improving host microbiota balance that could be targeted to a selected consumer group. Blood group secretor status, determining the ABO status, could be used to stratify the consumer group. We have applied a validated upper intestinal tract model (TIM-1) and culturing methods to screen potential probiotic bacteria from faeces of blood secretor and non-secretor individuals. Faecal samples from healthy volunteers were pooled to age- and sex-matched secretor and non-secretor pools. Faecal pools were run through separate TIM-1 simulations, and bacteria were cultivated from samples taken at different stages of simulations for characterisation. Microbes in secretor pool survived the transit through TIM-1 system better than microbes of non-secretor pool, especially bifidobacteria and anaerobes were highly affected. The differences in numbers of bifidobacteria and lactobacilli isolates after plate cultivations and further the number of distinct RAPD-genotypes was clearly lower in non-secretor pool than in secretor pool. In the present study, we showed that microbiota of secretor and non-secretor individuals tolerate gastrointestinal conditions differently and that a combination of gastrointestinal simulations and cultivation methods proved to be a promising tool for isolating potentially probiotic bacteria.
- 18 June 2012
- Published by Co-Action Publishing in Microbial Ecology in Health and Disease
- Vol. 23
Open AccessIsolation of bifidobacteria for blood group secretor status targeted personalised nutrition
Currently, there is a constant need to find microbial products for maintaining or even improving host microbiota balance that could be targeted to a selected consumer group. Blood group secretor status, determining the ABO status, could be used to stratify the consumer group. We have applied a validated upper intestinal tract model (TIM-1) and culturing methods to screen potential probiotic bacteria from faeces of blood secretor and non-secretor individuals. Faecal samples from healthy volunteers were pooled to age- and sex-matched secretor and non-secretor pools. Faecal pools were run through separate TIM-1 simulations, and bacteria were cultivated from samples taken at different stages of simulations for characterisation. Microbes in secretor pool survived the transit through TIM-1 system better than microbes of non-secretor pool, especially bifidobacteria and anaerobes were highly affected. The differences in numbers of bifidobacteria and lactobacilli isolates after plate cultivations and further the number of distinct RAPD-genotypes was clearly lower in non-secretor pool than in secretor pool. In the present study, we showed that microbiota of secretor and non-secretor individuals tolerate gastrointestinal conditions differently and that a combination of gastrointestinal simulations and cultivation methods proved to be a promising tool for isolating potentially probiotic bacteria.
- Open Access
- 27 March 2012
- Published by Springer Nature in BMC Microbiology
- Vol. 12 (1) , 47
Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine
Background: Antibiotic associated diarrhea and Clostridium difficile infection are frequent complications of broad spectrum antibiotic therapy. Probiotic bacteria are used as therapeutic and preventive agents in these disorders, but the exact functional mechanisms and the mode of action are poorly understood. The effects of clindamycin and the probiotic mixture VSL#3 (containing the 8 bacterial strains Streptococcus thermophilus, Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei and Lactobacillus delbrueckii subsp. Bulgaricus) consecutively or in combination were investigated and compared to controls without therapy using a standardized human fecal microbiota in a computer-controlled in vitro model of large intestine. Microbial metabolites (short chain fatty acids, lactate, branched chain fatty acids, and ammonia) and the intestinal microbiota were analyzed. Results: Compared to controls and combination therapy, short chain fatty acids and lactate, but also ammonia and branched chain fatty acids, were increased under probiotic therapy. The metabolic pattern under combined therapy with antibiotics and probiotics had the most beneficial and consistent effect on intestinal metabolic profiles. The intestinal microbiota showed a decrease in several indigenous bacterial groups under antibiotic therapy, there was no significant recovery of these groups when the antibiotic therapy was followed by administration of probiotics. Simultaneous application of anti- and probiotics had a stabilizing effect on the intestinal microbiota with increased bifidobacteria and lactobacilli. Conclusions: Administration of VSL#3 parallel with the clindamycin therapy had a beneficial and stabilizing effect on the intestinal metabolic homeostasis by decreasing toxic metabolites and protecting the endogenic microbiota from destruction. Probiotics could be a reasonable strategy in prevention of antibiotic associated disturbances of the intestinal homeostasis and disorders.
- 27 March 2012
- Published by Springer Nature in BMC Microbiology
- Vol. 12 (1) , 47
Open AccessEffects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine
Background: Antibiotic associated diarrhea and Clostridium difficile infection are frequent complications of broad spectrum antibiotic therapy. Probiotic bacteria are used as therapeutic and preventive agents in these disorders, but the exact functional mechanisms and the mode of action are poorly understood. The effects of clindamycin and the probiotic mixture VSL#3 (containing the 8 bacterial strains Streptococcus thermophilus, Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei and Lactobacillus delbrueckii subsp. Bulgaricus) consecutively or in combination were investigated and compared to controls without therapy using a standardized human fecal microbiota in a computer-controlled in vitro model of large intestine. Microbial metabolites (short chain fatty acids, lactate, branched chain fatty acids, and ammonia) and the intestinal microbiota were analyzed. Results: Compared to controls and combination therapy, short chain fatty acids and lactate, but also ammonia and branched chain fatty acids, were increased under probiotic therapy. The metabolic pattern under combined therapy with antibiotics and probiotics had the most beneficial and consistent effect on intestinal metabolic profiles. The intestinal microbiota showed a decrease in several indigenous bacterial groups under antibiotic therapy, there was no significant recovery of these groups when the antibiotic therapy was followed by administration of probiotics. Simultaneous application of anti- and probiotics had a stabilizing effect on the intestinal microbiota with increased bifidobacteria and lactobacilli. Conclusions: Administration of VSL#3 parallel with the clindamycin therapy had a beneficial and stabilizing effect on the intestinal metabolic homeostasis by decreasing toxic metabolites and protecting the endogenic microbiota from destruction. Probiotics could be a reasonable strategy in prevention of antibiotic associated disturbances of the intestinal homeostasis and disorders.
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Effects of Pro- and Antibiotics on the Intestinal Homeostasis in a Computer Controlled Model of the Large Intestine
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Effects of Pro- and Antibiotics on the Intestinal Homeostasis in a Computer Controlled Model of the Large Intestine